• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Pediatrix Medical Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement

    4/18/25 4:30:09 PM ET
    $MD
    Hospital/Nursing Management
    Health Care
    Get the next $MD alert in real time by email
    8-K
    false000089394900008939492025-04-152025-04-15

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): April 15, 2025

     

     

     

     

    img261191455_0.jpg

    Pediatrix Medical Group, Inc.

    (Exact name of Registrant as Specified in Its Charter)

     

     

    Florida

    001-12111

    26-3667538

    (State or Other Jurisdiction
    of Incorporation)

    (Commission File Number)

    (IRS Employer
    Identification No.)

     

     

     

     

     

    1301 Concord Terrace

     

    Sunrise, Florida

     

    33323

    (Address of Principal Executive Offices)

     

    (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: 954 384-0175

     

     

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:


    Title of each class

     

    Trading
    Symbol(s)

     


    Name of each exchange on which registered

    Common Stock, par value $.01 per share

     

    MD

     

    The New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     


    Item 1.01 Entry into a Material Definitive Agreement.

     

    On April 15, 2025, PMG Services, Inc. (“PMG Services”), a Florida corporation and wholly-owned subsidiary of Pediatrix Medical Group, Inc., and Guidehouse Managed Services LLC, a Delaware limited liability company (“Guidehouse”), agreed to amend Statement of Work #1 under that certain Master Services Agreement, dated as of April 19, 2024, between PMG Services and Guidehouse (as amended, the “Agreement”), to, among other things, extend the term from April 19, 2025 through June 30, 2025.

    Also on April 15, 2025, PMG Services and Guidehouse entered into a certain Statement of Work #2 under the Agreement pursuant to which Guidehouse will provide certain services to PMG Services commencing July 1, 2025. In exchange for the provision of the services described therein, PMG Services will pay Guidehouse (i) certain fixed payments, (ii) certain variable payments and (iii) certain incentive payments based on Guidehouse’s achievement of certain performance metrics, in each case as calculated in accordance therewith.

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

     

    Pediatrix Medical Group, Inc.

     

     

     

     

    Date:

    April 18, 2025

    By:

    /s/ Kasandra H. Rossi

     

     

     

    Kasandra H. Rossi
    Chief Financial Officer

     


    Get the next $MD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MD

    DatePrice TargetRatingAnalyst
    12/16/2024Outperform
    Macquarie
    9/26/2024$8.00 → $14.00Hold → Buy
    Jefferies
    6/7/2024$8.00Sell → Hold
    Deutsche Bank
    2/23/2022$32.00 → $31.00Outperform
    Credit Suisse
    12/22/2021$33.00 → $32.00Outperform
    Credit Suisse
    11/4/2021$29.00 → $27.00Market Perform
    SVB Leerink
    9/27/2021$29.00Market Perform
    SVB Leerink
    8/9/2021$30.00 → $32.00Neutral
    Mizuho
    More analyst ratings

    $MD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Pediatrix Medical Group Reports First Quarter Results

      Raises Full Year 2025 Adjusted EBITDA Outlook Range Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.24 per share for the three months ended March 31, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.33. For the 2025 first quarter, Pediatrix reported the following results: Net revenue of $458 million; Net income of $21 million; and Adjusted EBITDA of $49 million. "Our strong first quarter results reflect same-unit top-line outperformance versus our expectations, continued steady cost management and the successful results of the portfolio restructuring we completed last year. As a result of our strong f

      5/6/25 6:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025

      Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Tuesday, May 6, 2025 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2025. A detailed press release will be issued the morning of May 6, 2025 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across

      4/21/25 7:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group Reports Fourth Quarter Results

      Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.36 per share for the three months ended December 31, 2024. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.51. For the 2024 fourth quarter, Pediatrix reported the following results: Net revenue of $502 million; Net income of $30 million; and Adjusted EBITDA of $69 million. "Our strong fourth quarter results reflect continued top-line outperformance versus our expectations, the completion of our portfolio restructuring, and the related overhead expense reductions," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group. "I am honored and excited

      2/20/25 6:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care

    $MD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Macquarie initiated coverage on Pediatrix Medical Group

      Macquarie initiated coverage of Pediatrix Medical Group with a rating of Outperform

      12/16/24 7:46:05 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group upgraded by Jefferies with a new price target

      Jefferies upgraded Pediatrix Medical Group from Hold to Buy and set a new price target of $14.00 from $8.00 previously

      9/26/24 7:37:57 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group upgraded by Deutsche Bank with a new price target

      Deutsche Bank upgraded Pediatrix Medical Group from Sell to Hold and set a new price target of $8.00

      6/7/24 8:14:20 AM ET
      $MD
      Hospital/Nursing Management
      Health Care

    $MD
    Leadership Updates

    Live Leadership Updates

    See more
    • Pediatrix Announces Strategic Initiatives For Enhanced Shareholder Value Creation

      Executive Chair Mark S. Ordan to Return as Chief Executive Officer Company Redoubles Strategic Focus on Physician Practices and Hospital and Health System Relationships Pediatrix Medical Group, Inc. (NYSE:MD) ("Pediatrix" or "the Company"), a leading provider of physician services, today announced a leadership transition to accelerate its progress in executing a transformational strategy designed to create value for shareholders and other stakeholders. To best position Pediatrix to implement the strategy, which is based on recommitting to the highest standards in clinical excellence and strengthening the Company's hospital relationships, the Company's Board of Directors has appointed Ex

      1/13/25 6:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Board Appoints Sylvia Young as Independent Director

      Pediatrix Medical Group, Inc. (NYSE:MD), the nation's leading provider of highly specialized health care for women, children and babies, today announced that its board of directors has appointed Sylvia Young, a recognized leader in healthcare and long-term healthcare executive, as an independent director, effective May 12, 2023. Ms. Young, a veteran of hospital administration since 1985, most recently served as President and CEO of the HCA Continental Division, a multi-state regional healthcare system that is part of Hospital Corporation of America (HCA). Prior to her appointment to the Denver-based Division headquarters, Ms. Young served as President of HCA's Sunrise Health System, inclu

      5/4/23 4:05:00 PM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • BurgerFi Appoints Vivian Lopez-Blanco to its Board of Directors

      PALM BEACH, Fla., July 15, 2021 (GLOBE NEWSWIRE) -- BurgerFi International, Inc. (NASDAQ:BFI, BFIIW))) ("BurgerFi" or the "Company"), one of the nation's fastest-growing premium fast-casual concepts, has appointed Vivian Lopez-Blanco to its board of directors, effective July 14, 2021. Lopez-Blanco's appointment follows the sudden passing of board member Steven Berrard announced on June 10, 2021. Lopez-Blanco has also been named as the chair of the audit committee and will be serving on the compensation committee and nominating governance committee. Lopez-Blanco is an experienced board member and seasoned finance executive with expertise in organizational transformations and driving prof

      7/15/21 7:30:00 AM ET
      $BFI
      $TAST
      $MD
      Restaurants
      Consumer Discretionary
      Hospital/Nursing Management
      Health Care

    $MD
    Financials

    Live finance-specific insights

    See more
    • Pediatrix Medical Group Reports First Quarter Results

      Raises Full Year 2025 Adjusted EBITDA Outlook Range Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.24 per share for the three months ended March 31, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.33. For the 2025 first quarter, Pediatrix reported the following results: Net revenue of $458 million; Net income of $21 million; and Adjusted EBITDA of $49 million. "Our strong first quarter results reflect same-unit top-line outperformance versus our expectations, continued steady cost management and the successful results of the portfolio restructuring we completed last year. As a result of our strong f

      5/6/25 6:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025

      Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Tuesday, May 6, 2025 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2025. A detailed press release will be issued the morning of May 6, 2025 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across

      4/21/25 7:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group Reports Fourth Quarter Results

      Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.36 per share for the three months ended December 31, 2024. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.51. For the 2024 fourth quarter, Pediatrix reported the following results: Net revenue of $502 million; Net income of $30 million; and Adjusted EBITDA of $69 million. "Our strong fourth quarter results reflect continued top-line outperformance versus our expectations, the completion of our portfolio restructuring, and the related overhead expense reductions," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group. "I am honored and excited

      2/20/25 6:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care

    $MD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Pediatrix Medical Group Inc.

      SC 13G - Pediatrix Medical Group, Inc. (0000893949) (Subject)

      11/13/24 4:30:24 PM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Pediatrix Medical Group Inc.

      SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

      10/31/24 11:54:57 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G/A filed by Pediatrix Medical Group Inc. (Amendment)

      SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

      6/10/24 12:43:02 PM ET
      $MD
      Hospital/Nursing Management
      Health Care

    $MD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, GC, Chief Admin Off & Sec Moore Mary Ann E gifted 26,497 shares, decreasing direct ownership by 21% to 100,338 units (SEC Form 4)

      4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

      3/7/25 5:00:10 PM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • EVP, CFO and Treasurer Rossi Kasandra H covered exercise/tax liability with 3,718 shares, decreasing direct ownership by 7% to 51,151 units (SEC Form 4)

      4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

      3/4/25 5:00:09 PM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • EVP, GC, Chief Admin Off & Sec Moore Mary Ann E covered exercise/tax liability with 8,975 shares, decreasing direct ownership by 7% to 126,835 units (SEC Form 4)

      4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

      3/4/25 5:00:17 PM ET
      $MD
      Hospital/Nursing Management
      Health Care

    $MD
    SEC Filings

    See more
    • Pediatrix Medical Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)

      5/8/25 4:30:14 PM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • SEC Form 10-Q filed by Pediatrix Medical Group Inc.

      10-Q - Pediatrix Medical Group, Inc. (0000893949) (Filer)

      5/6/25 7:00:19 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)

      5/6/25 6:50:08 AM ET
      $MD
      Hospital/Nursing Management
      Health Care